Cardiosense receives FDA Breakthrough Device designation for algorithm to identify patients at risk of decompensated heart failure

/PRNewswire/ -- Cardiosense, Inc., a Chicago-based digital health company building a physiological waveform AI platform to manage cardiac disease, announced...

Related Keywords

Chicago ,Illinois ,United States ,Amit Gupta ,Luke Neill ,Markc Smith ,Liviu Klein ,Mozziyar Etemadi ,Breakthrough Devices Program ,Clinical Affairs ,Breakthrough Device Program ,Prnewswire Cardiosense Inc ,National Institutes Of Health ,Drug Administration ,Georgia Institute Of Technology ,Breakthrough Device ,Omer Inan ,Georgia Institute ,Medical Director ,Advanced Technologies ,National Institutes ,Section Chief ,Advanced Heart Failure ,Mechanical Circulatory Support ,Pulmonary Hypertension ,Heart Transplantation ,Lead Clinical Advisor ,Cardiosense ,